Ann: Preliminary Final Report , page-2

DDT: Last weeks full year results were solid with a profit of $931K on revenue of $10.0m (up 23% from last year). Cash at the bank has increased to $1.8m at June 30. The company's recent announcement of a deal with a world leading European pharmaceutical company to use DataTraceDNA to authenticate the entire production volume of one of its most successful drug lines was also very significant. If this is a success then I'd expect further applications in this area. News Due: Further commercialisation agreements for Verify TT which is aimed at protecting products against counterfeiting. In an ASX announcement in March VTT disclosed that several high profile brands within the fashion industry were evaluating the technology owned by DDT's 50/50 JV company DataTraceDNA Pty Ltd. Agreements were expected within 3 months so they are now overdue. Price Target: The chart looks good however more volume is needed to move prices higher. Support is now at 3 cents and the first resistance is at 3.5 cents followed by 4 cents. Disclosure: No Stock Held